MDMA’s 2022 FDA Forum will feature senior officials from FDA and industry and focus on the
key regulatory issues impacting the medical device industry.
Designed specifically for medical device regulatory professionals and executive decision makers,
MDMA’s FDA Forum promises to deliver key regulatory insights and preview trends
that will impact your regulatory and business strategies.
Topics will include:
FDA’s Continued COVID-19 Response
Navigating 510(k), De Novo, PMA Programs
Best Practices for Pre-Submission meetings
Emerging Issues (Biocompatibility, Supply Chain & More)
This conference is pre-approved by RAPS as eligible for up to 6 credits
towards a participant’s RAC recertification upon full completion